Begin, Arabella Simpkin http://orcid.org/0000-0001-6652-8789
Hata, Susan
Berkowitz, Lori R.
Plessow, Franziska
Lawson, Elizabeth A.
Emptage, Nigel
Armstrong, Katrina
Funding for this research was provided by:
Eric M. Mindich Research Fund for the Foundations of Human Behavior, Harvard Univeristy (N/A)
Center for Educational Innovation and Scholarship, Massachusetts General Hospital (N/A, N/A)
National Institutes of Health (K24MH120568)
Article History
Received: 3 October 2020
Accepted: 22 March 2021
First Online: 26 April 2021
Declarations
:
: The Institutional Review Board of the organizing hospital (Partners Healthcare, Protocol number: 2018P000415) approved the study. Written consent was obtained from all participants. All data used were strictly anonymized; only a research coordinator had access to the file linking responses to identifiers.All authors had full access to all the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.
: EAL is on the scientific advisory board and has a financial interest in OXT Therapeutics, a company developing an intranasal oxytocin and long-acting analogs of oxytocin to treat obesity and metabolic disease. EAL’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. All other authors report no declarations of interest.
Free to read: This content has been made available to all.